Answers are grounded in this paper and cite their sources.
Introduction: Minimal extrathyroidal extension (mETE) is an adverse feature of papillary thyroid microcarcinoma (PTMC), but its preoperative identification remains challenging. Objective: To develop and validate a dual-phase contrast-enhanced computed tomography (CT) radiomics model and evaluate the complementary value of clinical factors for predicting mETE in PTMC. Methods: This retrospective study included 311 patients with pathologically confirmed PTMC, randomly assigned to training (n = 217) and testing (n = 94) cohorts. Radiomics features were extracted from arterial- and venous-phase contrast-enhanced CT images and reduced using correlation analysis and least absolute shrinkage and selection operator logistic regression. Independent clinical and conventional imaging predictors were identified by multivariable logistic regression. Clinical, radiomics, and combined models were evaluated by receiver operating characteristic curve analysis, calibration, decision curve analysis, net reclassification improvement, and integrated discrimination improvement. Results: Thirty-eight radiomics features were retained. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and ultrasonographic capsular contact status were independent predictors of mETE. In the training cohort, the clinical, radiomics, and combined models achieved areas under the curve (AUCs) of 0.765, 0.916, and 0.923, respectively; corresponding AUCs in the testing cohort were 0.615, 0.822, and 0.825. Both the radiomics and combined models demonstrated significantly better discrimination than the clinical model, whereas their difference was not statistically significant (p = 0.894). Conclusion: The dual-phase CT radiomics model showed good discrimination for mETE in PTMC. Clinical factors provided complementary information but did not significantly improve discrimination. The radiomics-based model may serve as an auxiliary tool for preoperative risk assessment. However, prospective multicenter studies and independent external validation are warranted to establish its clinical utility.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: